Celecoxib Dosing and PPI Requirements

Recommended Dosing and PPI Co-therapy

The American Family Physician recommends proton pump inhibitor co-therapy for patients with a history of peptic ulcer disease or NSAID-related GI complications, advanced age (≥65 years), concomitant use of anticoagulants, concomitant use of corticosteroids, high-dose or multiple NSAIDs, or concomitant low-dose aspirin use 1, 2, 5, 6, 7
The American Heart Association suggests that all NSAIDs, including celecoxib, may increase the risk of serious cardiovascular events, and celecoxib may be safer than other COX-2 inhibitors regarding cardiovascular risk, but caution is still warranted 3, 8
The European Heart Journal recommends using the minimum PPI dose required to treat symptoms, and if used for >12 weeks, clinical rationale should support an underlying chronic disease or risk factors 6
The American Family Physician recommends monitoring blood pressure, as celecoxib can increase mean blood pressure by approximately 5 mm Hg, and considering monitoring renal function in patients at risk of renal failure and those taking ACE inhibitors or ARBs 1, 8
The Nature Reviews Rheumatology suggests that in patients with increased cardiovascular risk, limit use of COX-2 inhibitors to 30 days, and patients ≥75 years should preferably use topical NSAIDs over oral NSAIDs including celecoxib 4

The American Heart Association suggests that celecoxib may increase the risk of serious cardiovascular events, and caution is still warranted in patients with increased cardiovascular risk 3
The Nature Reviews Rheumatology recommends that patients ≥75 years should preferably use topical NSAIDs over oral NSAIDs including celecoxib 4
The European Heart Journal recommends monitoring for potential PPI adverse effects including Clostridium difficile infection, hypomagnesemia, and bone loss/fractures 6

The American Family Physician recommends monitoring for signs of GI bleeding, especially in high-risk patients, and regular assessment of continued need for therapy to minimize adverse effects 2
The American Family Physician suggests considering monitoring renal function in patients at risk of renal failure and those taking ACE inhibitors or ARBs 1